European equity markets opened lower on Monday, with AstraZeneca shares continuing their downward trajectory.
The pharmaceutical giant remains a focal point of selling pressure, dragging on broader index performance as investors navigate a cautious trading environment.
The decline in AstraZeneca follows a session last Thursday where the FTSE 100 fell 16.59 points to close at 10,472.45, weighed down by disappointment surrounding the company's outlook.
The Stockholm Stock Exchange also opened lower, extending the negative momentum that has gripped European bourses.
Market sentiment remains fragile in the wake of renewed military activity between the United States and Iran over the weekend.
Geopolitical risks are compounding corporate-specific headwinds, leading to a broad risk-off posture among institutional investors.